• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of transcriptional control mechanism for the expression of type I collagen gene in fibrotic skin disorders

Research Project

Project/Area Number 10670779
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Dermatology
Research InstitutionChiba University

Principal Investigator

HATAMOCHI Atsushi  Chiba University School of Medicine, Associate Professor, 医学部, 助教授 (90172923)

Co-Investigator(Kenkyū-buntansha) ENDO Hideharu  Chiba University School of Medicine, Assistant, 医学部, 助手 (50282489)
SHINKAI Hiroshi  Chiba University School of Medicine, Professor, 医学部, 教授 (90030957)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2000: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1999: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1998: ¥1,000,000 (Direct Cost: ¥1,000,000)
Keywordstype I collagen / transcription / fibrotic skin diseases / ColF1 / type III collagen / ColF1 / α_2(I)コラーゲン / Ehlers-Danlos症候群 / cutis laxa / acrogeria / Cutis laxa
Research Abstract

Type I collagen, a most abundant protein in the dermis, consists of two α1(I) chain and one α 2(I) chain which are coordinately expressed. ColF1, a DNA binding protein which specifically binds to a segment of the α2(I) collagen promoter at -400bp upstream of the start of transcription, activates transcription of the α2(I) collagen gene in vitro, and consists of two polypeptides. We investigated on the the cDNA cloning of this transcriptional factor of the α2(I) collagen gene. We found that 42kDa polypeptide were identical to Pur α, is a nuclear protein which has been reported to binds to a upstream region of human c-mye gene, and 40kDa polypeptide were identical to Pur β, has been partially sequenced and has regions of strong homology to Pur α. Full length of Pur β cDNA were sequenced. We had looked for fibroblasts express abnormal levels of collagen as model systems of transcriptional control mechanisms of type I collagen gene in vivo. We found two strains of Ehlers-Danlos syndrome fibroblasts which produced extremely low levels of type III collagen.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report

Research Products

(13 results)

All Other

All Publications (13 results)

  • [Publications] Hatamochi, A.: "Regulation of matrix metalloproteinase(MMP)expression in cutis laxa fibroblasts : upregulation of MMP-1, -3 and-9 genes but not-2 gene"Brit J Dermatol. 138. 757-762 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsukifuji, R.: "Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis"Brit J Cancer. 80. 1087-1091 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hatamochi, A.: "Costello syndrome with decreased gene expression of elastin in cultured dermal fibroblasts"Dermatology. 201. 366-369 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nishiyama, Y.: "Ehlers-Danlos syndrome type IV with a unigue point mutation in the COL3A1 and familial phenotype of myocardial infarction"J Intern Med. in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hatamochi, A.: "Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts : upregulation of MMP-1, MMP-3 and MMP-9 genes but not of the MMP-2 gene."Brit J Dermatol.. 138(5). 757-762 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsukifuji, R.: "Expression of matrix metalloproteinase-1 , -2 and -3 in squamous cell carcinoma and actinic keratosis."Brit J Cancer.. 80(7). 1087-1091 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hatamochi, A.: "Costello syndrome with decreased gene expression of elastin in cultured dermal fibroblasts."Dermatology. 201(4). 366-369 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nishiyama, Y.: "Ehlers-Danlos syndrome type IV with a unique point mutation in the COL3A1 and familial phenotype of myocardial infarction without organic coronary stenosis."J Intern Med. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hatamodri,A.: "Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts : upregulation of MMP-1, -3 and -9 genes but not-2 gen"Brit J Dermatol. 138(5). 757-762 (1998)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsukifuji,R.: "Expression of matrix metalloproteinase -1, -2 and -3 in squamous cell carcinoma and actinic keratosis"Brit J Cancer. 80(7). 1087-1091 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hatamochi,A.: "Costello syndrome with decreased gene expression of elastin in cultured clermal fibroblasts"Dermatology. 201(4). 366-369 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Nishiyama,Y.: "Ehlers-Danlos syndrome type TV with a unique point mutation in the CoL3A1 and familial phenotype of myocardial infarction"J.Intern Med. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsukifuji, R.: "Expression of matrix metalloproteinase-1,-2 and -3 in squamous cell carcinoma and actinic keratosis"Brit. J. Cancer. 80・7. 1087-1091 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1998-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi